OQROSign up free
Insider trade

City Therapeutics (CTY): Director exercised options on 56K units

John Maraganore, Director at City Therapeutics, reported an option exercise of 56K units.

56K
Derivative units
Traded
Oct 19, 2026
Filed
Oct 20, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 15, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
  2. Oct 19, 2026Insider · 2 peopleInsiders: 2 purchases (~$6.1M)

What came next

  1. Oct 22, 20265% stakeRaymond Debbane reported a passive stake (13G) of 8.1%
  2. Oct 26, 20265% stakeVIKING GLOBAL INVESTORS LP reported a passive stake (13G) of 7.0%
  3. Oct 26, 20265% stakeARCH Venture Fund XII, L.P. filed an activist stake (13D) of 25.6%
  4. Nov 6, 20265% stakeFMR LLC reported a passive stake (13G) of 14.0%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for City Therapeutics

For City Therapeutics, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 4 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CTY page.

Other recent filings by John Maraganore, Director

The full history of John Maraganore, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at City Therapeutics

Everything OQRO holds on this company is on its CTY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data